Shares of Rocket Lab Corporation (NASDAQ:RKLB - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the thirteen brokerages that are presently covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokers that have updated their coverage on the stock in the last year is $42.2727.
A number of brokerages have recently issued reports on RKLB. Cantor Fitzgerald raised their price target on shares of Rocket Lab from $35.00 to $54.00 and gave the stock an "overweight" rating in a report on Friday, August 8th. Citigroup restated a "buy" rating and set a $50.00 price target (up previously from $33.00) on shares of Rocket Lab in a report on Monday, July 14th. Stifel Nicolaus lifted their target price on shares of Rocket Lab from $34.00 to $55.00 and gave the company a "buy" rating in a report on Tuesday, August 5th. Bank of America lifted their target price on shares of Rocket Lab from $30.00 to $50.00 and gave the company a "buy" rating in a report on Wednesday, July 16th. Finally, KeyCorp lifted their target price on shares of Rocket Lab from $40.00 to $50.00 and gave the company an "overweight" rating in a report on Friday, August 8th.
Check Out Our Latest Stock Report on Rocket Lab
Rocket Lab Price Performance
Shares of RKLB traded up $0.6210 during mid-day trading on Tuesday, hitting $41.3110. 7,586,879 shares of the company were exchanged, compared to its average volume of 19,912,330. Rocket Lab has a 1-year low of $5.74 and a 1-year high of $53.44. The company has a debt-to-equity ratio of 0.60, a quick ratio of 2.33 and a current ratio of 2.67. The company has a 50 day moving average of $40.06 and a 200-day moving average of $28.60. The stock has a market cap of $19.80 billion, a price-to-earnings ratio of -91.72 and a beta of 2.17.
Rocket Lab (NASDAQ:RKLB - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The rocket manufacturer reported ($0.13) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by ($0.06). The business had revenue of $144.50 million during the quarter, compared to analyst estimates of $135.42 million. Rocket Lab had a negative net margin of 45.87% and a negative return on equity of 48.14%. The firm's revenue was up 35.9% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.08) EPS. Rocket Lab has set its Q3 2025 guidance at EPS. Analysts expect that Rocket Lab will post -0.38 EPS for the current fiscal year.
Insider Buying and Selling at Rocket Lab
In other Rocket Lab news, insider Frank Klein sold 2,546 shares of the firm's stock in a transaction that occurred on Monday, June 9th. The shares were sold at an average price of $30.00, for a total value of $76,380.00. Following the completion of the transaction, the insider owned 1,365,826 shares of the company's stock, valued at $40,974,780. This trade represents a 0.19% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Merline Saintil sold 6,353 shares of the firm's stock in a transaction that occurred on Tuesday, June 24th. The shares were sold at an average price of $33.38, for a total transaction of $212,063.14. Following the completion of the transaction, the director directly owned 419,569 shares of the company's stock, valued at $14,005,213.22. This represents a 1.49% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 1,130,995 shares of company stock worth $29,686,039 over the last ninety days. Company insiders own 11.90% of the company's stock.
Institutional Investors Weigh In On Rocket Lab
Hedge funds and other institutional investors have recently modified their holdings of the company. EverSource Wealth Advisors LLC raised its holdings in shares of Rocket Lab by 109.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 796 shares of the rocket manufacturer's stock valued at $28,000 after purchasing an additional 416 shares in the last quarter. Atlantic Union Bankshares Corp acquired a new stake in Rocket Lab during the 2nd quarter worth $36,000. Kilter Group LLC acquired a new stake in Rocket Lab during the 2nd quarter worth $37,000. ORG Partners LLC raised its stake in Rocket Lab by 491.9% during the 2nd quarter. ORG Partners LLC now owns 1,095 shares of the rocket manufacturer's stock worth $38,000 after acquiring an additional 910 shares in the last quarter. Finally, Golden State Wealth Management LLC raised its stake in Rocket Lab by 3,250.0% during the 2nd quarter. Golden State Wealth Management LLC now owns 1,340 shares of the rocket manufacturer's stock worth $48,000 after acquiring an additional 1,300 shares in the last quarter. 71.78% of the stock is currently owned by institutional investors and hedge funds.
About Rocket Lab
(
Get Free Report)
Rocket Lab USA, Inc, a space company, provides launch services and space systems solutions for the space and defense industries. The company provides launch services, spacecraft design services, spacecraft components, spacecraft manufacturing, and other spacecraft and on-orbit management solutions; and constellation management services, as well as designs and manufactures small and medium-class rockets.
Further Reading

Before you consider Rocket Lab, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.
While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.